POSTER 60
- Kelley Tangredi
- Apr 30
- 1 min read
Updated: Jul 2
Impact of calcipotriene and betamethasone dipropionate cream with PAD technology (CAL/BDP PAD cream) on patient symptoms, functioning, emotions, level of itching, and sleep quality among patients with mild-to-moderate scalp psoriasis in routine clinical practices in Europe. An interim analysis of the PRO-SCALP study
Andreas Pinter, Jose Luis López Estebaranz, Anthony Bewley, Jordi Galván, Siva Narayanan, Volker Koscielny, Ismail Kasujee
< Previous Poster | Next Poster >


